河診斷

2013年7月19日

2007年11月28日，TechFund今天宣布完成“A輪融資”。該輪融資由伊拉斯謨MC生物醫學基金和技術基金共同牽頭。River Diagnostics開發並將醫療診斷儀器推向市場，這些儀器使用了一種名為拉曼光譜的光學技術。最近，該公司推出了在菌株水平上輕鬆快速識別細菌的技術，這將成為對抗醫院獲得性感染的關鍵工具。它將使感染預防小組能夠監測細菌在醫院中的傳播和傳播，並將在由MRSA等眾所周知的“醫院細菌”引起的汙染和潛在爆發的情況下提供早期預警。該公司的另一項業務集中在皮膚病學領域。它的皮膚成分分析儀提供了關於皮膚成分的詳細信息，以及關於局部應用產品的滲透力和效果。River Diagnostics首席執行官Gerwin Puppels:“我們非常高興本輪融資的結束，以及Erasmus MC Biomedical Fund和TechFund等兩家經驗豐富的風險資本投資者參與了我們公司的成功。此次融資將使River Diagnostics能夠推出其微生物鑒定設備，並進一步發展其其他業務。伊拉斯謨MC生物醫學基金合夥人湯姆·施瓦茨說:“我們很高興對River Diagnostics進行這項投資。”“該公司的微生物識別設備不僅在菌株水平上實時識別微生物，而且在一夜培養步驟後以每小時100個樣品的快速、高通量方式進行識別，擊敗了黃金標準。 Given the knowledge of the company’s scientific team, it is obvious that many more applications will be developed and commercialized by River Diagnostics in the coming years. I am looking forward to working closely with the management team as a new member of the company’s Supervisory Board.” About River Diagnostics (www.riverd.com) River Diagnostics develops and brings innovative solutions for clinical diagnostics and life sciences R&D to market, based on the vast potential of Raman spectroscopy for cell and tissue characterization. River Diagnostics addresses unmet needs and untapped markets in clinical diagnostics and life sciences R&D with products and services based on Raman spectroscopy; an optical technology, which enables detailed analysis of cells and tissues. The company was founded as a spin-out of the Center for Optical Diagnostics and Therapy of the Erasmus-university Medical Center in Rotterdam, The Netherlands, with which it continues to maintain a close working relationship. About TechFund B.V. (www.tiin.net) Based in Soest, TechFund B.V. invests in ICT, Nano and Medical technology. TechFund is founded by TIIN (The Informal Investors Network BV) and Atlantic Capital B.V. and funded by a group of 35 business angels. TechFund is cofunded by TechnoPartner, a Dutch agency supported by the Department of Economic Affairs that provided seed funds. For more information, please visit www.tiin.net and www.atlanticcapital.nl About the Erasmus MC Biomedical Fund (www.erasmusmcfund.nl) The Erasmus MC Biomedical Fund is an independent venture capital fund focusing on early stage companies and (university) spin-outs in the biotechnology and biomedical field with a presence in the Rotterdam region. The fund targets companies that are developing commercially promising products and technologies in life sciences, including pharmaceuticals, biotechnology, information technology and other high technology opportunities that offer venture capital returns. For further information please contact: Willem van den Berg